Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. NovoCure Limited
  6. Calendar
    NVCR   JE00BYSS4X48

NOVOCURE LIMITED

(NVCR)
  Report
Real-time Estimate Cboe BZX  -  01:25 2022-10-06 pm EDT
85.71 USD   +0.88%
10/03Novocure to Report Third Quarter 2022 Financial Results
BU
09/30Insider Sell: Novocure
MT
09/21Novocure Announces Creation of U.S. CNS Cancers Franchise Intended to Renew Focus on Growth in Glioblastoma Business
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart NOVOCURE LIMITED
Upcoming events on NOVOCURE LIMITED
10/27/22 Q3 2022 Earnings Release (Projected)
02/23/23 FY 2022 Earnings Release (Projected)
04/27/23 Q1 2023 Earnings Release (Projected)
07/27/23 Interim 2023 Earnings Release (Projected)
Past events on NOVOCURE LIMITED
09/13/22 H.C. Wainwright Global Investment Conference
09/07/22 | 04:20pm Wells Fargo Healthcare Conference
07/28/22 | 08:00am Interim 2022 Earnings Call
07/28/22 | 07:00am Interim 2022 Earnings Release
06/08/22 | 09:00am Annual General Meeting
04/28/22 | 08:00am Q1 2022 Earnings Call
04/28/22 | 07:00am Q1 2022 Earnings Release
04/08/22 American Association of Cancer Research Meeting - Abstract No CT234
04/08/22 American Association of Cancer Research Meeting - Abstract No 4138
04/08/22 American Association of Cancer Research Meeting - Abstract No 3447
Past dividends on NOVOCURE LIMITED

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
177
177
0,00%
248
247
0,51%
351
351
0,05%
494
494
0,14%
535
539
-0,81%
 
548
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-31,7
-10,5
-200%


 
7,55
9,20
-18%
39,6
40,3
-1,9%
-34,1
-20,6
-66%
 
-64,8
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-39,3
-42,3
7,0%
-33,7
-31,7
-6,3%
-0,91
6,79
-113%
30,4
34,9
-13%
-44,3
-28,8
-54%
 
-76,8
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-48,5
-53,3
9,0%
-45,9
-44,6
-3,0%
-8,82
-2,12
-316%
18,1
25,8
-30%
-52,1
-36,7
-42%
 
-87,4
 
Net income
M $
Released
Forecast
Spread
-61,7
-59,9
-2,9%
-63,6
-61,3
-3,7%
-7,23
-10,5
31%
19,8
28,8
-31%
-58,4
-41,1
-42%
 
-86,5
 
EPS
$
Released
Forecast
Spread
-0,70
-0,68
-3,1%
-0,69
-0,65
-5,7%
-0,07
-0,10
32%
0,20
0,26
-24%
-0,56
-0,41
-37%
 
-0,81
 
Announcement Date02/22/201802/28/201902/27/202002/25/202102/24/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
134
142
-5,9%
134
141
-5,4%
133
134
-0,95%
138
134
2,4%
141
135
4,2%
 
134
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-9,82
4,92
-300%
-5,82
-5,96
2,4%
-20,7
-4,23
-390%
1,80
-20,3
109%
-18,5
-11,6
-60%
 
-23,8
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-12,3
2,79
-541%
-8,55
-6,34
-35%
-23,4
-7,85
-198%
-0,81
-18,4
96%
-21,1
-12,9
-64%
 
-25,8
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-13,2
2,10
-729%
-10,5
-7,76
-36%
-25,6
-10,2
-151%
-2,52
-22,1
89%
-23,4
-15,7
-48%
 
-28,9
 
Net income
M $
Released
Forecast
Spread
-14,6
1,23
-1 286%
-13,1
-7,57
-73%
-26,5
-11,1
-138%
-4,65
-19,9
77%
-24,0
-15,6
-53%
 
-28,9
 
EPS
$
Released
Forecast
Spread
-0,14
0,01
-1 698%
-0,13
-0,07
-76%
-0,25
-0,11
-134%
-0,04
-0,19
79%
-0,23
-0,14
-59%
 
-0,28
 
Announcement Date07/29/202110/28/202102/24/202204/28/202207/28/2022-
Previous year Next Year
Upcoming sector events for NOVOCURE LIMITED
More events
Past sector events for NOVOCURE LIMITED
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise